论文部分内容阅读
我们测定了原发性肝癌(Hepatocellular Carcino-ma,HCC)和肝硬化(Liver Cirrhosis,LC)病人外周血中可溶性白介素Ⅱ受体(sIL—2R)、人Ⅲ型前胶原(hPcⅢ)、透明质酸(HA)、ALT、γ—GTT的水平的变化,并分析了它们之间的相互关系,试图了解IC和HCC患者外周血sIL—2R与肝纤维化的关系。 材料和方法 一、对象:经临床诊断的病毒性肝炎后肝硬化(LC)病人47例(男35,女12),年龄21～74岁,平均51.4岁。伴肝硬化的原发性肝癌(HCC)病人29例(男19,女10),年龄31～70岁,平均55.6岁(1977年全国肝癌协作会议制定的肝癌诊断标准)。正常对照选健康人24例(男19,女5),年龄23～72岁,平均49.7岁。
We measured the levels of soluble interleukin 2 receptor (sIL-2R), human type III procollagen (hPcIII), and hyaluronan in peripheral blood of patients with hepatocellular carcinoma (HCC) and cirrhosis (Cirrhosis) (HA), ALT, γ-GTT, and analyzed the relationship between them, trying to understand the relationship between sIL-2R and hepatic fibrosis in peripheral blood of patients with IC and HCC. MATERIALS AND METHODS 1. Subjects: 47 clinically diagnosed cirrhosis patients (35 males and 12 females) with liver cirrhosis (LC), aged 21-74 years (average 51.4 years). Twenty-nine patients (19 males and 10 females) with cirrhosis of primary liver cancer (HCC), aged from 31 to 70 years old, with an average age of 55.6 years (liver cancer diagnostic criteria developed by the National Liver Cancer Collaborative Conference in 1977). Normal control selected healthy 24 (male 19, female 5), aged 23 to 72 years, mean 49.7 years old.